Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Metastases to bone
ADR ID BADD_A07415
ADR Hierarchy
15      Musculoskeletal and connective tissue disorders
15.09      Musculoskeletal and connective tissue neoplasms
15.09.03      Malignant musculoskeletal and connective tissue neoplasms
15.09.03.006      Metastases to bone
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.22      Metastases
16.22.02      Metastases to specified sites
16.22.02.005      Metastases to bone
Description Not Available
MedDRA Code 10027452
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Bone metastases | Bony metastases | Bony secondaries | Metastases to bone | Secondary malignant neoplasm of bone and bone marrow | Osteolytic bone metastases | Osteoblastic bone metastases
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01378Memantine0.000363%
BADD_D01601Olaparib0.001007%
BADD_D01629Osimertinib0.002295%
BADD_D01653Paclitaxel0.000392%
BADD_D01654Palbociclib0.002183%
BADD_D01662Pamidronic acid--
BADD_D01687Pazopanib0.001500%
BADD_D01777Pioglitazone0.000215%
BADD_D01913Ranitidine--
BADD_D01922Regorafenib0.000895%
BADD_D02029Sitagliptin0.000212%
BADD_D02058Sorafenib0.002071%
BADD_D02100Sunitinib--
BADD_D02105Tacrolimus0.000891%
BADD_D02111Tamoxifen0.000238%
BADD_D02150Temozolomide0.000224%
BADD_D02257Trametinib0.000112%
BADD_D02331Valsartan0.000132%
BADD_D02334Vandetanib0.000112%
BADD_D02392Zoledronic acid0.023476%
BADD_D02412Octreotide0.000466%
BADD_D02464Fingolimod0.002170%
BADD_D02483Ribociclib0.001175%
BADD_D02489Neratinib0.000112%
BADD_D02490Apalutamide0.001502%
BADD_D02498Abemaciclib0.000548%
BADD_D02500Alpelisib0.000280%
BADD_D02509Brigatinib0.000280%
BADD_D02548Darolutamide0.001168%
BADD_D02567Lutetium lu-177 vipivotide tetraxetan-
The 2th Page    First    Pre   2 3    Next   Last    Total 3 Pages